entertainment -WSS

entertainment

author：explore 2025-09-30 22:06:11 - browse：48

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution.

“What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that “the impact on health care costs would be very marginal.”

The problem, executives say, is that companies developing cancer drugs today generally start small and then go big. They seek approval first in a small setting, such as patients who have exhausted all other therapies, where it’s easiest in terms of trial size and length to show a benefit. Then they go into larger settings, such as newly diagnosed patients, where studies take longer but the revenue potential is much higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Google says AlphaFold 3 can map a vast universe of biomolecules

WSS

H5N1 bird flu: what we're starting to learn about infection in cows

What to make of Biden’s latest efforts on cancer research

Brain worms: The science behind RFK Jr.'s parasitic infection

Dairy farmers resist CDC push for PPE against bird flu virus

New weight loss drugs vying to be the next Wegovy or Mounjaro

Popular nasal decongestant doesn't actually relieve congestion

knowledge

entertainment

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Long Covid needs a new name — and a new frame

Medical leaders decry Supreme Court decision on affirmative action

Software glitch causes Tandem insulin pump to shutdown, FDA warns

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Sanofi strikes deal with Novavax, boosting the vaccine maker

Novavax promises a turnaround & Lilly roils the obesity market

White House touts steps to stem shortages of cancer treatments

What does generative AI mean for health care? We asked experts

White House touts steps to stem shortages of cancer treatments

explore

Food makers tried to stack nutrition panel with preferred experts

Private equity could exacerbate cardiology's overuse problem, experts fear

H5N1 bird flu: what we're starting to learn about infection in cows

Use wet bulb globe temperature, not heat index, to protect workers

Diverse clinical trials: Why aren’t we there yet?

After gene therapy, two congenitally deaf children hear for the first time

hotspot

entertainment

focus

leisure time